Delivery Order SPE2DB20D3101-SPE2DB22FH9D2
Award Date
2/24/22
Potential Completion Date
2/25/22
Potential Value
$31K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product, to the Defense Logistics Agency (DLA). The $11,196.00 firm-fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on October 22, 2021, with a completion date of October 25, 2021. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccines to the Defense Logistics Agency (DLA). The $7,255.27 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of November 27, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccines to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on April 28, 2022, with a ceiling value of $62,931.20 and an ultimate completion date of April 29, 2022. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite...
This federal contract award, valued at $27,241.17, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 1, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products...
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product, to the Defense Logistics Agency (DLA). The $11,624.16 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 12, 2024, with a completion date of December 13, 2024. This is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive...
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccine to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for a ceiling value of $2,911.25. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is February 1, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product, to the Defense Logistics Agency (DLA). The $2,573.22 contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on March 2, 2022, with a completion date of March 3, 2022. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded on April 26, 2024, has a ceiling value of $18,726.20 and a completion date of April 29, 2024. The contract is a Firm Fixed Price Delivery Order, and there is no set-aside designation. Amerisourcebergen Drug Corp is a...
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product, to the Defense Logistics Agency (DLA). The contract has been awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $10,377.66, and has an ultimate completion date of January 31, 2024. This award is not designated with a set-aside...
This federal contract award, valued at $7,537.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company and subsidiary of Cencora, Inc. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, which is a vaccine product. The contract has an ultimate completion date of October 24, 2023 and is a firm fixed-price delivery order. The contract award is not associated with a set-aside designation, indicating it was...